Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors.

0 avis

Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors.

Archive ouverte

Boularot, Adrien | Giglione, Carmela | Artaud, Isabelle | Meinnel, Thierry

Edité par CCSD ; Thomson Reuters (Professional) -

Peptide deformylase inhibitors (PDFIs) appear to be one of the most exciting classes of antibacterial agents discovered to date. Rapid progress in the development of PDFIs has been possible because peptide deformylase is a metalloprotease, and this class of enzymes shows a high degree of structure-function conservation, and because the most potent PDFIs are hydroxamate derivatives, a well known category of pharmacophores. The current challenge in structure-activity relationship analysis is obtaining molecules with potent in vivo antibacterial activity against a range of drug-resistant pathogens. The PDFIs currently in clinical trials target community-based bacterial infections, with a potential major pharmaceutical market.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Trapping conformational states along ligand-binding dynamics of peptide deformylase: the impact of induced fit on enzyme catalysis.

Archive ouverte | Fieulaine, Sonia | CCSD

International audience. For several decades, molecular recognition has been considered one of the most fundamental processes in biochemistry. For enzymes, substrate binding is often coupled to conformational changes...

Discovery and Refinement of a New Structural Class of Potent Peptide Deformylase Inhibitors

Archive ouverte | Boularot, Adrien | CCSD

International audience

Discovery and Refinement of a New Structural Class of Potent Peptide Deformylase Inhibitors.

Archive ouverte | Boularot, Adrien | CCSD

New classes of antibiotics are urgently needed to counter increasing levels of pathogen resistance. Peptide deformylase (PDF) was originally selected as a specific bacterial target, but a human homologue, the inhibition of which c...

Chargement des enrichissements...